Fexuprazan

DRUG3 trials

Sponsors

Daewoong Pharmaceutical Co. LTD., Indonesia University, Ewha Womans University Mokdong Hospital

Conditions

Atrial Fibrillation (AF)Drug-Related Side Effects and Adverse ReactionsGastro Oesophageal Reflux DiseaseGastroesophageal Reflux DiseaseGastrointestinal Hemorrhage (Clinically Important, Upper)Upper Gastrointestinal Bleeding (UGIB)

Phase 3

Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease

CompletedNCT07326904

Indonesia UniversityGastro Oesophageal Reflux Disease

Start: 2024-08-28End: 2024-12-13Updated: 2026-08-24

Unknown Phase

Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

CompletedNCT05614752

Daewoong Pharmaceutical Co. LTD.Gastroesophageal Reflux Disease

Start: 2022-07-06End: 2024-11-08Updated: 2025-01-24

FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)

Not yet recruitingNCT07497893

Ewha Womans University Mokdong HospitalAtrial Fibrillation (AF), Drug-Related Side Effects and Adverse Reactions, Gastrointestinal Hemorrhage (Clinically Important, Upper) +1

Start: 2026-12-01End: 2032-11-30Target: 1000Updated: 2026-03-27